Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Alzheimer's disease (AD) is a common neurodegenerative disease in the elderly. The main manifestations of patients are the decline of cognitive function, mental symptoms and behavioral disorders, and the gradual decline of daily living ability.
The report presented by Global Market Monitor provides a detailed analysis of the various factors driving the growth of the global Alzheimer’s Disease Drug market. The report provides a comprehensive assessment of the various factors affecting the Alzheimer’s Disease Drug market and provides space for strategic planning. High prices for advanced Alzheimer’s Disease Drug are hampering the market in less developed countries in the Asia-Pacific region. In recent years, the prevalence of neurodegenerative diseases has increased in some countries (e.g the United States), which has led to steady government support for drug development. The rising prevalence of the disease in developed Western countries is the prime driver for the global Alzheimer’s drugs market. Increasing government support for mental healthcare infrastructure in several developing countries/regions in the Asia-Pacific region is likely to drive the Alzheimer's drug market in the region in the coming years. The rising awareness about neurodegenerative diseases in developing regions such as Asia Pacific is likely to be a key contributor to the global Alzheimer’s drugs market in the coming years. The global Disease Alzheimer’s Drugs Market is expected to generate revenue of around USD 5.8 billion by end of 2026, growing at a CAGR of around 9% between 2020 and 2026.
This report elaborates on the current development of the Alzheimer’s Disease Drug industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Johnson & Johnson
Eisai
Pfizer
Merz Pharma
Novartis
Allergan
By Type:
Rivastigmine
Donepezil
Memantine
By Application:
Early to Moderate Stages
Moderate to Severe Stages
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Alzheimer’s Disease Drug Market Overview 2018-2029
-
1.1 China Alzheimer’s Disease Drug Industry Development Overview
-
1.2 China Alzheimer’s Disease Drug Industry Development History
-
1.3 China Alzheimer’s Disease Drug Industry Market Size (2018-2029)
-
1.4 China Alzheimer’s Disease Drug Market Analysis by Type from Production Side
-
1.4.1 China Alzheimer’s Disease Drug Production Volume, Production Value and Growth Rate of Rivastigmine (2018-2029)
-
1.4.2 China Alzheimer’s Disease Drug Production Volume, Production Value and Growth Rate of Donepezil (2018-2029)
-
1.4.3 China Alzheimer’s Disease Drug Production Volume, Production Value and Growth Rate of Memantine (2018-2029)
-
1.5 China Alzheimer’s Disease Drug Market Analysis by Application from Consumption End
-
1.5.1 China Alzheimer’s Disease Drug Sales Volume, Sales Value and Growth Rate of Early to Moderate Stages (2018-2029)
-
1.5.2 China Alzheimer’s Disease Drug Sales Volume, Sales Value and Growth Rate of Moderate to Severe Stages (2018-2029)
-
1.6 China Alzheimer’s Disease Drug Market Analysis by Region
-
1.6.1 North China Alzheimer’s Disease Drug Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Alzheimer’s Disease Drug Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Alzheimer’s Disease Drug Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Alzheimer’s Disease Drug Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Alzheimer’s Disease Drug Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Alzheimer’s Disease Drug Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Alzheimer’s Disease Drug Market Size and Growth Rate from 2018-2029
Chapter 2 China Alzheimer’s Disease Drug Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Alzheimer’s Disease Drug Market Status and Competition at home and abroad in 2023
-
2.2.2 China Alzheimer’s Disease Drug Market Status and Competition Analysis in 2023
-
2.2.3 China Alzheimer’s Disease Drug Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Alzheimer’s Disease Drug Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Alzheimer’s Disease Drug Industry Development
Chapter 3 Alzheimer’s Disease DrugIndustry Chain Analysis
-
3.1 Alzheimer’s Disease Drug Industry Chain
-
3.2 Alzheimer’s Disease Drug Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Alzheimer’s Disease Drug Market
-
3.3 Alzheimer’s Disease Drug Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Alzheimer’s Disease Drug Market
Chapter 4 China Alzheimer’s Disease Drug Market, by Type
-
4.1 China Alzheimer’s Disease Drug Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Alzheimer’s Disease Drug Total Production Volume and Growth Rate from Production Side
-
4.5 China Alzheimer’s Disease Drug Production Volume and Growth Rate, by Type
-
4.5.1 China Alzheimer’s Disease Drug Production Volume and Growth Rate of Rivastigmine
-
4.5.2 China Alzheimer’s Disease Drug Production Volume and Growth Rate of Donepezil
-
4.5.3 China Alzheimer’s Disease Drug Production Volume and Growth Rate of Memantine
Chapter 5 China Alzheimer’s Disease Drug Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Alzheimer’s Disease Drug Total Market Size and Growth Rate from Consumption End
-
5.5 China Alzheimer’s Disease Drug Market Size and Growth Rate, by Application
-
5.5.1 China Alzheimer’s Disease Drug Market Size and Growth Rate of Early to Moderate Stages
-
5.5.2 China Alzheimer’s Disease Drug Market Size and Growth Rate of Moderate to Severe Stages
Chapter 6 China Alzheimer’s Disease Drug Market, by Region
-
6.1 China Alzheimer’s Disease Drug Production Volume and Production Value, by Region
-
6.2 China Alzheimer’s Disease Drug Sales Volume and Sales Value, by Region
Chapter 7 North China Alzheimer’s Disease Drug Market Analysis
-
7.1 North China Alzheimer’s Disease Drug Market, by Type
-
7.2 North China Alzheimer’s Disease Drug Market, by Application
Chapter 8 Central China Alzheimer’s Disease Drug Market Analysis
-
8.1 Central China Alzheimer’s Disease Drug Market, by Type
-
8.2 Central China Alzheimer’s Disease Drug Market, by Application
Chapter 9 South China Alzheimer’s Disease Drug Market Analysis
-
9.1 South China Alzheimer’s Disease Drug Market, by Type
-
9.2 South China Alzheimer’s Disease Drug Market, by Application
Chapter 10 East China Alzheimer’s Disease Drug Market Analysis
-
10.1 East China Alzheimer’s Disease Drug Market, by Type
-
10.2 East China Alzheimer’s Disease Drug Market, by Application
Chapter 11 Northeast China Alzheimer’s Disease Drug Market Analysis
-
11.1 Northeast China Alzheimer’s Disease Drug Market, by Type
-
11.2 Northeast China Alzheimer’s Disease Drug Market, by Application
Chapter 12 Southwest China Alzheimer’s Disease Drug Market Analysis
-
12.1 Southwest China Alzheimer’s Disease Drug Market, by Type
-
12.2 Southwest China Alzheimer’s Disease Drug Market, by Application
Chapter 13 Northwest China Alzheimer’s Disease Drug Market Analysis
-
13.1 Northwest China Alzheimer’s Disease Drug Market, by Type
-
13.2 Northwest China Alzheimer’s Disease Drug Market, by Application
Chapter 14 Company Profiles
-
14.1 Johnson & Johnson
-
14.1.1 Johnson & Johnson Company Profile
-
14.1.2 Johnson & Johnson Alzheimer’s Disease Drug Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Eisai
-
14.2.1 Eisai Company Profile
-
14.2.2 Eisai Alzheimer’s Disease Drug Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Pfizer
-
14.3.1 Pfizer Company Profile
-
14.3.2 Pfizer Alzheimer’s Disease Drug Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Merz Pharma
-
14.4.1 Merz Pharma Company Profile
-
14.4.2 Merz Pharma Alzheimer’s Disease Drug Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Novartis
-
14.5.1 Novartis Company Profile
-
14.5.2 Novartis Alzheimer’s Disease Drug Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Allergan
-
14.6.1 Allergan Company Profile
-
14.6.2 Allergan Alzheimer’s Disease Drug Market Performance
-
14.6.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Alzheimer’s Disease Drug Industry Research Conclusions
-
15.2 Alzheimer’s Disease Drug Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Alzheimer’s Disease Drug Industry Market Size (2018-2029)
-
Figure China Alzheimer’s Disease Drug Production Volume, Production Value and Growth Rate of Rivastigmine (2018-2029)
-
Figure China Alzheimer’s Disease Drug Production Volume, Production Value and Growth Rate of Donepezil (2018-2029)
-
Figure China Alzheimer’s Disease Drug Production Volume, Production Value and Growth Rate of Memantine (2018-2029)
-
Figure China Alzheimer’s Disease Drug Sales Volume, Sales Value and Growth Rate of Early to Moderate Stages (2018-2029)
-
Figure China Alzheimer’s Disease Drug Sales Volume, Sales Value and Growth Rate of Moderate to Severe Stages (2018-2029)
-
Figure North China Alzheimer’s Disease Drug Market Size and Growth Rate from 2018-2029
-
Figure Central China Alzheimer’s Disease Drug Market Size and Growth Rate from 2018-2029
-
Figure South China Alzheimer’s Disease Drug Market Size and Growth Rate from 2018-2029
-
Figure East China Alzheimer’s Disease Drug Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Alzheimer’s Disease Drug Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Alzheimer’s Disease Drug Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Alzheimer’s Disease Drug Market Size and Growth Rate from 2018-2029
-
Figure Alzheimer’s Disease Drug Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Alzheimer’s Disease Drug Market Share by Type in 2018
-
Figure China Alzheimer’s Disease Drug Market Share by Type in 2023
-
Figure China Alzheimer’s Disease Drug Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Alzheimer’s Disease Drug Production Volume and Growth Rate of Rivastigmine (2018-2023)
-
Figure China Alzheimer’s Disease Drug Production Volume and Growth Rate of Donepezil (2018-2023)
-
Figure China Alzheimer’s Disease Drug Production Volume and Growth Rate of Memantine (2018-2023)
-
Figure China Alzheimer’s Disease Drug Market Share by Application in 2018
-
Figure China Alzheimer’s Disease Drug Market Share by Application in 2023
-
Figure China Alzheimer’s Disease Drug Total Market Size and Growth Rate from Consumption End
-
Figure China Alzheimer’s Disease Drug Market Size and Growth Rate of Early to Moderate Stages (2018-2023)
-
Figure China Alzheimer’s Disease Drug Market Size and Growth Rate of Moderate to Severe Stages (2018-2023)
-
Table China Alzheimer’s Disease Drug Production Volume by Region (2018-2023)
-
Table China Alzheimer’s Disease Drug Production Volume Share by Region (2018-2023)
-
Figure China Alzheimer’s Disease Drug Production Volume Share by Region (2018-2023)
-
Table China Alzheimer’s Disease Drug Production Value by Region (2018-2023)
-
Table China Alzheimer’s Disease Drug Production Value Share by Region (2018-2023)
-
Figure China Alzheimer’s Disease Drug Production Value Share by Region (2018-2023)
-
Table China Alzheimer’s Disease Drug Sales Volume by Region (2018-2023)
-
Table China Alzheimer’s Disease Drug Sales Volume Share by Region (2018-2023)
-
Figure China Alzheimer’s Disease Drug Sales Volume Share by Region (2018-2023)
-
Table China Alzheimer’s Disease Drug Sales Value by Region (2018-2023)
-
Table China Alzheimer’s Disease Drug Sales Value Share by Region (2018-2023)
-
Figure China Alzheimer’s Disease Drug Sales Value Share by Region (2018-2023)
-
Table North China Alzheimer’s Disease Drug Production Volume by Type (2018-2023)
-
Table North China Alzheimer’s Disease Drug Production Volume Share by Type (2018-2023)
-
Figure North China Alzheimer’s Disease Drug Production Volume Share by Type (2018-2023)
-
Table North China Alzheimer’s Disease Drug Sales Volume by Application (2018-2023)
-
Table North China Alzheimer’s Disease Drug Sales Volume Share by Application (2018-2023)
-
Figure North China Alzheimer’s Disease Drug Sales Volume Share by Application (2018-2023)
-
Table Central China Alzheimer’s Disease Drug Production Volume by Type (2018-2023)
-
Table Central China Alzheimer’s Disease Drug Production Volume Share by Type (2018-2023)
-
Figure Central China Alzheimer’s Disease Drug Production Volume Share by Type (2018-2023)
-
Table Central China Alzheimer’s Disease Drug Sales Volume by Application (2018-2023)
-
Table Central China Alzheimer’s Disease Drug Sales Volume Share by Application (2018-2023)
-
Figure Central China Alzheimer’s Disease Drug Sales Volume Share by Application (2018-2023)
-
Table South China Alzheimer’s Disease Drug Production Volume by Type (2018-2023)
-
Table South China Alzheimer’s Disease Drug Production Volume Share by Type (2018-2023)
-
Figure South China Alzheimer’s Disease Drug Production Volume Share by Type (2018-2023)
-
Table South China Alzheimer’s Disease Drug Sales Volume by Application (2018-2023)
-
Table South China Alzheimer’s Disease Drug Sales Volume Share by Application (2018-2023)
-
Figure South China Alzheimer’s Disease Drug Sales Volume Share by Application (2018-2023)
-
Table East China Alzheimer’s Disease Drug Production Volume by Type (2018-2023)
-
Table East China Alzheimer’s Disease Drug Production Volume Share by Type (2018-2023)
-
Figure East China Alzheimer’s Disease Drug Production Volume Share by Type (2018-2023)
-
Table East China Alzheimer’s Disease Drug Sales Volume by Application (2018-2023)
-
Table East China Alzheimer’s Disease Drug Sales Volume Share by Application (2018-2023)
-
Figure East China Alzheimer’s Disease Drug Sales Volume Share by Application (2018-2023)
-
Table Northeast China Alzheimer’s Disease Drug Production Volume by Type (2018-2023)
-
Table Northeast China Alzheimer’s Disease Drug Production Volume Share by Type (2018-2023)
-
Figure Northeast China Alzheimer’s Disease Drug Production Volume Share by Type (2018-2023)
-
Table Northeast China Alzheimer’s Disease Drug Sales Volume by Application (2018-2023)
-
Table Northeast China Alzheimer’s Disease Drug Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Alzheimer’s Disease Drug Sales Volume Share by Application (2018-2023)
-
Table Southwest China Alzheimer’s Disease Drug Production Volume by Type (2018-2023)
-
Table Southwest China Alzheimer’s Disease Drug Production Volume Share by Type (2018-2023)
-
Figure Southwest China Alzheimer’s Disease Drug Production Volume Share by Type (2018-2023)
-
Table Southwest China Alzheimer’s Disease Drug Sales Volume by Application (2018-2023)
-
Table Southwest China Alzheimer’s Disease Drug Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Alzheimer’s Disease Drug Sales Volume Share by Application (2018-2023)
-
Table Northwest China Alzheimer’s Disease Drug Production Volume by Type (2018-2023)
-
Table Northwest China Alzheimer’s Disease Drug Production Volume Share by Type (2018-2023)
-
Figure Northwest China Alzheimer’s Disease Drug Production Volume Share by Type (2018-2023)
-
Table Northwest China Alzheimer’s Disease Drug Sales Volume by Application (2018-2023)
-
Table Northwest China Alzheimer’s Disease Drug Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Alzheimer’s Disease Drug Sales Volume Share by Application (2018-2023)
-
Table Johnson & Johnson Company Profile
-
Table Johnson & Johnson Alzheimer’s Disease Drug Revenue, Price and Gross (2018-2023)
-
Table Eisai Company Profile
-
Table Eisai Alzheimer’s Disease Drug Revenue, Price and Gross (2018-2023)
-
Table Pfizer Company Profile
-
Table Pfizer Alzheimer’s Disease Drug Revenue, Price and Gross (2018-2023)
-
Table Merz Pharma Company Profile
-
Table Merz Pharma Alzheimer’s Disease Drug Revenue, Price and Gross (2018-2023)
-
Table Novartis Company Profile
-
Table Novartis Alzheimer’s Disease Drug Revenue, Price and Gross (2018-2023)
-
Table Allergan Company Profile
-
Table Allergan Alzheimer’s Disease Drug Revenue, Price and Gross (2018-2023)
-
